Defect of interleukin-2 production and T cell proliferation in atopic patients: restoring ability of the CD28-mediated activation pathway.
Romano MF, Turco MC, Stanziola A, Giarrusso PC, Petrella A, Tassone P, van Lier R, Venuta S, Formisano S.
Romano MF, et al. Among authors: venuta s.
Cell Immunol. 1993 May;148(2):455-63. doi: 10.1006/cimm.1993.1127.
Cell Immunol. 1993.
PMID: 8098674
F., Valerio, G., Turco, M. C., Spadaro, G., Venuta, S., and Formisono, S., Cell. Immunol. 139, 91, 1992). We have subsequently analyzed T cell response to anti-CD2, -CD3, or -CD28 monoclonal antibodies (mAb) in 40 atopic individuals, including patients subjec …
F., Valerio, G., Turco, M. C., Spadaro, G., Venuta, S., and Formisono, S., Cell. Immunol. 139, 91, 1992). We have subse …